Amphastar Pharmaceuticals (AMPH) Net Equity Issued and Repurchased (2015)
Amphastar Pharmaceuticals (AMPH) posted quarterly Net Equity Issued and Repurchased of $9.8 million for Q2 2015, up 978.35% quarter-over-quarter from $910000.0 in Q1 2015.
Amphastar Pharmaceuticals (AMPH) Net Equity Issued and Repurchased (2015) Analysis & Trends
Amphastar Pharmaceuticals' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $9.8 million for Q2 2015.
- In Q2 2015, Net Equity Issued and Repurchased changed N/A year-over-year to $9.8 million; the TTM figure through Jun 2015 stood at $10.7 million (changed N/A YoY), while the FY2014 annual figure was $38.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q2 2015 stood at $9.8 million, up from $910000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $9.8 million in Q2 2015, with the low at $910000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 9.81 Mn |
| Jun 30, 2015 | 9.81 Mn |
| Mar 31, 2015 | 910,000.00 |
| Mar 31, 2015 | 910,000.00 |